These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2534452)

  • 1. [Understanding microcapillary angioma, observations in pregnant patients and in females treated with hormonal contraceptives].
    Bantel E; Grosshans E; Ortonne JP
    Z Hautkr; 1989 Dec; 64(12):1071-4. PubMed ID: 2534452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microcapillary hemangioma].
    Satge D; Grande-Goburdhun J; Grosshans E
    Ann Dermatol Venereol; 1993; 120(4):297-8. PubMed ID: 8239379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What does the micropill bring?].
    Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
    Weijers MJ
    Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
    Weijers MJ
    Fortschr Med; 1982 Apr; 100(16):764-7. PubMed ID: 6211403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrent bleeding of thalamic cavernous angioma under hormonal treatment. A case report].
    Gazzaz M; Sichez J; Capelle L; Fohanno D
    Neurochirurgie; 1999 Dec; 45(5):413-6. PubMed ID: 10717593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desogestrel-containing oral contraceptives and blood pressure.
    Dieben TO; van Beek A
    Arzneimittelforschung; 1986 Nov; 36(11):1678-80. PubMed ID: 2949757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
    Cremer P; Vekemans M
    Rev Med Brux; 1987 Nov; 8(9):440-6. PubMed ID: 3423522
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 18. Chorea induced by the use of oral contraceptives. Report of a case and review of the literature.
    Galimberti D
    Ital J Neurol Sci; 1987 Aug; 8(4):383-6. PubMed ID: 2960635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern extremely low dose oral contraception with lindynette 20].
    Radinski G
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():40-2. PubMed ID: 19504706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.